IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas (vol 158, pg, 173, 2022)
AMERICAN JOURNAL OF CLINICAL PATHOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined